Heparin sodium identification is a reference standard used for structural and compositional verification of UFH. It enables spectroscopic and chromatographic analysis to ensure the identity of heparin in pharmaceutical products.

The USP biologics carbohydrates category includes a variety of carbohydrate-based substances that are essential in the development and manufacturing of therapeutic products. These carbohydrates play crucial roles in biological processes and are often utilized as excipients, stabilizers, or active ingredients in pharmaceuticals. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of carbohydrate therapeutics throughout their lifecycle.

The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

Heparin Sodium is the sodium salt of sulfated glycosaminoglycans. It is a mixture of heterogeneous molecules varying in molecular weights with a combination of activities against different factors of the blood clotting cascade. It is present in mammalian tissues and is usually obtained from the intestinal mucosa or other suitable tissues of domestic mammals used for food by humans. Heparin sodium identification USP reference standard is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Heparin sodium identification USP reference standard is used to prepare standard solution and system suitability solution for the identification and analysis of heparin sodium using specific methods as described in the United States Pharmacopeia (USP) monographs. Further information is available in chapter, Heparin Sodium, USP43-NF38 – 2195 of USP.

Heparin Sodium is the sodium salt of sulfated glycosaminoglycans. It is a mixture of heterogeneous molecules varying in molecular weights with a combination of activities against different factors of the blood clotting cascade. It is present in mammalian

Heparin Sodium is the sodium salt of sulfated glycosaminoglycans. It is a mixture of heterogeneous molecules varying in molecular weights with a combination of activities against different factors of the blood clotting cascade. It is present in mammalian tissues and is usually obtained from the intestinal mucosa or other suitable tissues of domestic mammals used for food by humans. Heparin sodium identification USP reference standard is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Sales restrictions may apply.

This product is part of the USP Biologics program.